Results 111 to 120 of about 56,993 (185)

Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosis. [PDF]

BMC Nephrol, 2013
Hatakeyama S, Murasawa H, Narita T, Oikawa M, Fujita N, Iwamura H, Mikami J, Kojima Y, Sato T, Fukushi K, Ishibashi Y, Hashimoto Y, Koie T, Saitoh H, Funyu T, Ohyama C.   +15 more
europepmc   +1 more source

Comparison of the effects of non-calcium and calcium-based phosphate binders on fibroblast growth factor-23 levels in patients with CKD-mineral and bone disorder: a meta-analysis of randomized controlled trials. [PDF]

BMC Nephrol
Cha S, Baek M, Jung C, Kim H.
europepmc   +1 more source

Pharmacological Management of Secondary Hyperparathyroidism in Dialysis Patients: A Narrative Review of Calcimimetics, Vitamin D Analogs, and Phosphate Binders. [PDF]

Cureus
Alwashahi H, Unnikrishnan Meenakshi D.
europepmc   +1 more source

Determination of residual epichlorohydrin in sevelamer hydrochloride by static headspace gas chromatography with flame ionization detection. [PDF]

Sci Pharm, 2010
Karthikeyan K, Arularasu GT, Devaraj P, Pillai KC.   +3 more
europepmc   +1 more source

Phosphate-latest news and ongoing trials. [PDF]

Clin Kidney J
Parpia AS, Kumra R, Mansell C, Harel Z, Perl J, Ben-Bassat OK, Wald R.   +6 more
europepmc   +1 more source

Association between Phosphate Binders and Constipation in Patients Undergoing Chronic Hemodialysis: A Cross-sectional Study. [PDF]

Intern Med
Hori M, Takahashi H, Kondo C, Takeda A, Morozumi K, Maruyama S.   +5 more
europepmc   +1 more source

Transient decrease of serum bicarbonate levels with Sevelamer hydrochloride as the phosphate binder [PDF]

Kidney International, 2000
M. Gallieni, M. Cozzolino, D. Brancaccio
openaire   +3 more sources

Evanescent extraosseous calcifications in low turnover bone: management and outcomes: a case report. [PDF]

Front Nephrol
Hernandez-Pérez M, Enos D.
europepmc   +1 more source

Emerging treatments and current strategies for mineral, vascular, and bone disorders in chronic kidney disease. [PDF]

World J Nephrol
Ilkun O, Jazayeri F, Kazory A.
europepmc   +1 more source

Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD). [PDF]

Cochrane Database Syst Rev
Natale P, Green SC, Ruospo M, Craig JC, Vecchio M, Elder GJ, Strippoli GF.   +6 more
europepmc   +1 more source